Our Approach
Community Involvement
Sheila Mikhail
Jennifer Anderson
Timothy Ferguson
Fred Johnson
Clinical Trials
Due Diligence
Entrepreneurial Services
Intellectual Property Management
Joint Ventures and Strategic Alliances
Mergers and Acquisitions
Reduction of Costs
Technology Transfers & Licensing
Venture Capital Financing
LSL Articles and Presentations
Research Triangle Resources
Entrepreneurial Resources
Life Sciences & Technology Resources
Firm News
Client News
Contact Us
Driving Directions

Mergers & Acquisitions

LSL attorneys have broad experience in mergers and acquisitions, including stock and asset deals. We can assist in the structuring, due diligence, financing and negotiation of such transactions. Some of the recent transactions concluded by our attorneys include:
  • Acquisition by an international pharmaceutical company of certain intellectual property assets of a bioinformatics company in a bankruptcy proceeding (asset acquisition)
  • Sale of ophthalmology related intellectual property assets by a virtual pharmaceutical company to a West Coast publicly traded pharmaceutical company (asset sale)
  • Sale of technology relating to receptors for Angiostatin to a West Coast publicly traded biotechnology company (asset sale)
  • Sale of a large regional health and life insurance brokerage business and related customer accounts (asset sale)
  • Sale of a large company representing a collaboration of various agricultural, manufacturing, marketing and distribution companies (stock sale)
  • Sale of a large health insurance subsidiary of a large diversified publicly traded life insurance company to another diversified publicly traded insurance company (stock sale)
  • Sale of a specialty services company to a publicly traded company (stock deal)
  • Sale of a large regional product distributor to another competing distributor (asset sale)
  • Acquisition of a privately held company by a publicly held company via a public merger (public merger and S-4 filing)
  • Investment by a large leveraged buyout fund and certain other parties in a mature product holding company and negotiation of the underlying bank loan and subordinated loan agreements (LBO)

©2013 Life Sciences Law